This placebo-controlled study will investigate the effect of tocilizumab (an anti-interleukin-6 receptor antibody) on symptom burden, physical functioning, and quality of life in patients with chronic pancreatitis.
Phase:
PHASE2
Details
Lead Sponsor:
Soren Schou Olesen
Collaborators:
Aarhus University Hospital Haukeland University Hospital Stanford University University of Aarhus Viborg Regional Hospital